Cardiac troponin risk stratification based on 99th percentile reference cutoffs in patients with ischemic symptoms suggestive of acute coronary syndrome - Influence of estimated glomerular filtration rates

被引:8
作者
Apple, Fred S.
Pearce, Lesly A.
Doyle, Patrick J.
Otto, Angela P.
Murakami, MaryAnn M.
机构
[1] Hennepin Cty Med Ctr, Clin Lab P4, Dept Lab Med & Pathol, Minneapolis, MN 55415 USA
[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[3] Biostat Consulting, Minot, ND USA
关键词
cardiac troponin; risk stratification; clinical chemistry; reference limits;
D O I
10.1309/17220CY5MK5UCQRP
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cardiac troponin (cTn) assays were compared in 490 unselected patients with symptoms suggestive of acute coronary syndrome with varying renal functions for risk stratification. cTnI (Dade, Newark, NJ; Beckman, Chaska, MN; and Tosoh, South San Francisco, CA) and cTnT (Roche, Indianapolis, IN) measurements and estimated glomerular filtration rates (eGFRs) were obtained and classified along sex-derived cutoffs. The cTn levels were increased in 14% to 25% of patients. In 68%, the eGFR was 60 mL/min/1.73 m(2) or more; in 17%, it was between 41 and 59; and in 15%, it was 40 or less. There were 36 deaths and 9 cardiac events. Risk stratification was significant at 30 days and 6 months (P <= .05). Relative risks ranged from 3.1 to 3.7, and cumulative event rates ranged from 22.4% to 24.2% for an increased troponin level compared with 6.7% to 8.9% for a normal level. The 6-month event rate with an eGFR less than 60 mL/min/1.73 m(2) and an increased troponin level ranged from 29.9% to 50.8% compared with 4.9% to 6.6% for a normal troponin level and an eGFR greater than 60 mL/min/1.73 m(2) (P < .05). The eGFR in combination with an increased cTn level demonstrated the most powerful stratification.
引用
收藏
页码:598 / 603
页数:6
相关论文
共 17 条
[1]  
[Anonymous], 2000, J AM SOC NEPHROL
[2]   Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology American College of Cardiology consensus recommendations [J].
Apple, FS ;
Quist, HE ;
Doyle, PJ ;
Otto, AP ;
Murakami, MM .
CLINICAL CHEMISTRY, 2003, 49 (08) :1331-1336
[3]   Prognostic value of the ortho vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia - Risk stratification using European Society of Cardiology American College of Cardiology recommended cutoff values [J].
Apple, FS ;
Murakami, MM ;
Quist, HH ;
Pearce, LA ;
Wieczorek, S ;
Wu, AHB .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (01) :114-120
[4]   European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials [J].
Apple, FS ;
Wu, AHB ;
Jaffe, AS .
AMERICAN HEART JOURNAL, 2002, 144 (06) :981-986
[5]   Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction [J].
Aviles, RJ ;
Askari, AT ;
Lindahl, B ;
Wallentin, L ;
Jia, G ;
Ohman, EM ;
Mahaffey, KW ;
Newby, LK ;
Califf, RM ;
Simoons, ML ;
Topol, EJ ;
Lauer, MS ;
Berger, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (26) :2047-2052
[6]   The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: A meta-analysis [J].
Heidenreich, PA ;
Alloggiamento, T ;
Melsop, K ;
McDonald, KM ;
Go, AS ;
Hlatky, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) :478-485
[7]   It's time for a change to a troponin standard [J].
Jaffe, AS ;
Ravkilde, J ;
Roberts, R ;
Naslund, U ;
Apple, FS ;
Galvani, M ;
Katus, H .
CIRCULATION, 2000, 102 (11) :1216-1220
[8]   N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease -: A Global Utilization of Strategies to Open occluded arteries (GUSTO)-IV substudy [J].
James, SK ;
Lindahl, B ;
Siegbahn, A ;
Stridsberg, M ;
Venge, P ;
Armstrong, P ;
Barnathan, ES ;
Califf, R ;
Topol, EJ ;
Simoons, ML ;
Wallentin, L .
CIRCULATION, 2003, 108 (03) :275-281
[9]   Cystatin C - A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome [J].
Jernberg, T ;
Lindahl, B ;
James, S ;
Larsson, A ;
Hansson, LO ;
Wallentin, L .
CIRCULATION, 2004, 110 (16) :2342-2348
[10]   Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes [J].
Lin, JC ;
Apple, FS ;
Murakami, MAM ;
Luepker, RV .
CLINICAL CHEMISTRY, 2004, 50 (02) :333-338